Related Experiment Video
Updated: May 30, 2026

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor
Published on: August 18, 2023
Effective date of requirement for premarket approval for three class III preamendments devices. Final rule
Abstract:
The Food and Drug Administration (FDA) is issuing a final rule to require the filing of a premarket approval application (PMA) or a notice of completion of a product development protocol (PDP) for the following three class III preamendments devices: Ventricular bypass (assist) device; pacemaker repair or replacement material; and female condom. The Agency has summarized its findings regarding the degree of risk of illness or injury designed to be eliminated or reduced by requiring the devices to meet the statute's approval requirements and the benefits to the public from the use of the devices. This action implements certain statutory requirements.
Related Concept Videos
FDA Approved Drugs: Changes to Approved Drugs
Drug Regulation
Clinically Relevant Drug Product Specifications: Methods of Establishment
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Endocarditis III: Medical Management

